Doximity Insider: 20,000 Shares Sold Under 10b5-1; Option Activity Reported
Rhea-AI Filing Summary
Timothy S. Cabral, a director of Doximity, Inc. (DOCS), reported transactions on 09/24/2025 showing conversions, a sale under a pre-established trading plan, and option activity. He converted 20,000 shares of Class B into Class A common stock and simultaneously sold 20,000 shares at $75 per share pursuant to a Rule 10b5-1 plan adopted on February 13, 2025, leaving 3,221 shares of Class A common stock beneficially owned. The filing also reports exercise/vesting-related option activity for 20,000 stock options with a $2.21 exercise price and references customary conversion terms for Class B shares.
Positive
- Conversion of 20,000 Class B shares into Class A shares was completed, clarifying share class alignment
- Option exercise/vesting activity is disclosed, showing exercise price of $2.21 for 20,000 options consistent with grant terms
- Sale executed under Rule 10b5-1 plan, indicating the sale followed a pre-established trading arrangement
Negative
- Insider sale of 20,000 shares at $75, reducing beneficial ownership to 3,221 shares
- Significant decrease in direct Class A holdings from the transactions reported
Insights
TL;DR: Insider sold 20,000 shares under a 10b5-1 plan while converting equivalent Class B shares; option exercise activity noted.
The sale of 20,000 Class A shares at $75 per share appears to be an automated transaction under an established Rule 10b5-1 trading plan, which reduces immediate insider ownership to 3,221 shares. The concurrent conversion of 20,000 Class B into Class A is described as an at-holder's-option conversion consistent with the company charter. Reported stock-option activity shows 20,000 options with a $2.21 exercise price tied to prior grants and vesting schedules. Overall, the transactions are routine insider liquidity and exercise mechanics rather than an operational signal.
TL;DR: Transactions follow standard governance mechanisms: conversion rights, 10b5-1 sale plan, and scheduled vesting/exercise.
The filing documents standard corporate governance events: conversion rights of Class B shares into Class A shares, automatic conversion triggers, and a Rule 10b5-1 sale that executed automatically. The option vesting and exercise details reference the original grant and monthly vesting schedule, consistent with executive equity arrangements. Disclosure includes a power of attorney signature, meeting Form 4 procedural requirements. These are disclosure-compliant actions rather than governance exceptions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 20,000 | $0.00 | -- |
| Exercise | Class B Common Stock | 20,000 | $0.00 | -- |
| Conversion | Class B Common Stock | 20,000 | $0.00 | -- |
| Conversion | Class A Common Stock | 20,000 | $0.00 | -- |
| Sale | Class A Common Stock | 20,000 | $75.00 | $1.50M |
Footnotes (1)
- Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2025. The stock option vested in 36 equal monthly installments after September 2, 2020, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on September 2, 2020. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the Issuer's initial public offering; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.
FAQ
What transactions did Timothy S. Cabral report on Form 4 for DOCS?
When did the reported transactions occur for DOCS insider Timothy Cabral?
Was the sale by the insider discretionary or pre-planned?
What is the exercise price and scope of the reported options?